IP Library › Assignment 017881/0581
Patent Assignment
Reel/Frame 017881/0581

Change of Name

Recorded: 2006-07-03 Pages: 4
Assignor
SYN X PHARMA INC.
Executed: 2006-02-09
Assignee
NANOGEN POINT OF CARE INC.
1 MARMAC DRIVE, TORONTO, ONTARIO, M9W 1E7, CANADA
Covered Property (1)
Fibronectin Precursor Biopolymer Markers Indicative of Alzheimer's Disease
Patent: 7,179,605 →
Application: 09/993,289 →
Publication: US 2006/0194337
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 13, 2002
From: JACKOWSKI, GEORGE PHD; MARSHALL, JOHN PHD
To: SYN X PHARMA
Reel/Frame 012622/0359 →
Security Interest Feb 12, 2004
From: SYNX PHARMA INC.
To: NANOGEN, INC.
Reel/Frame 014337/0010 →
Assignment of Assignor's Interest Aug 7, 2006
From: NANOGEN POINT OF CARE INC.
To: NANOGEN INC.
Reel/Frame 018067/0795 →
Assignment of Intellectual Property Security Agreement Apr 15, 2008
From: THE CANADA TRUST COMPANY
To: NANOGEN, INC.
Reel/Frame 020807/0247 →
Release of Security Interest Apr 17, 2008
From: NANOGEN POINT OF CARE, INC.
To: NANOGEN, INC.
Reel/Frame 020826/0087 →
Grant of Security Interest Jul 25, 2008
From: NANOGEN, INC.
To: PORTSIDE GROWTH & OPPORTUNITY FUND, AS COLLATERAL AGENT
Reel/Frame 021291/0605 →